203 related articles for article (PubMed ID: 2430436)
21. Applications of biologic tumor markers in testicular cancer.
Javadpour N
Cancer Treat Rep; 1979; 63(9-10):1643-7. PubMed ID: 91433
[TBL] [Abstract][Full Text] [Related]
22. Histologically pure stage I seminoma with an elevated beta-hCG of 4497 IU/l.
Bjurlin MA; August CZ; Weldon-Linne M; Totonchi E
Urology; 2007 Nov; 70(5):1007.e13-5. PubMed ID: 18068467
[TBL] [Abstract][Full Text] [Related]
23. Recurrence in nonseminomatous germ cell testis tumor patients with no viable tumor at postchemotherapy retroperitoneal lymph node dissection.
Spiess PE; Tannir NM; Brown GA; Liu P; Tu SM; Evans JG; Pisters LL
Urology; 2007 Dec; 70(6):1173-8. PubMed ID: 18158041
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of BHCG and local tumor invasion in stage I seminoma of the testis.
Schwartz BF; Auman R; Peretsman SJ; Moul JW; Deshon GE; Hernandez J; Rozanski RA; Thrasher JB
J Surg Oncol; 1996 Feb; 61(2):131-3. PubMed ID: 8606544
[TBL] [Abstract][Full Text] [Related]
25. Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissection.
Beck SD; Foster RS; Bihrle R; Einhorn LH; Donohue JP
J Clin Oncol; 2005 Sep; 23(25):6149-56. PubMed ID: 16135481
[TBL] [Abstract][Full Text] [Related]
26. False positive beta-human chorionic gonadotropin in testicular cancer.
Mohler JL; Siami PF; Flanigan RC
Urology; 1987 Sep; 30(3):252-4. PubMed ID: 2442873
[TBL] [Abstract][Full Text] [Related]
27. Tumor marker levels in post-chemotherapy cystic masses: clinical implications for patients with germ cell tumors.
Beck SD; Patel MI; Sheinfeld J
J Urol; 2004 Jan; 171(1):168-71. PubMed ID: 14665869
[TBL] [Abstract][Full Text] [Related]
28. Postoperative reduction of serum beta-HCG in testicular seminoma.
Sakashita S; Demura T; Gotoh T; Maru A; Koyanagi T
Int Urol Nephrol; 1988; 20(3):281-6. PubMed ID: 2456999
[TBL] [Abstract][Full Text] [Related]
29. Spermatic cord beta-human chorionic gonadotropin levels in seminoma and their clinical implications.
Mumperow E; Hartmann M
J Urol; 1992 Apr; 147(4):1041-3. PubMed ID: 1372658
[TBL] [Abstract][Full Text] [Related]
30. Cross-reactivity of a commercial chemiluminescence immunoassay for human chorionic gonadotropin with the free beta-subunit.
Luppa P; Spöttl G; Saller B; Neumeier D; Mann K
J Biolumin Chemilumin; 1992 Jul; 7(3):195-201. PubMed ID: 1381136
[TBL] [Abstract][Full Text] [Related]
31. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.
Habuchi T; Kamoto T; Hara I; Kawai K; Nakao M; Nonomura N; Kobayashi T; Ogawa O; Kamidono S; Akaza H; Okuyama A; Kato T; Miki T
Cancer; 2003 Oct; 98(8):1635-42. PubMed ID: 14534879
[TBL] [Abstract][Full Text] [Related]
32. [Subacute cerebellar degeneration with HCG-beta positive seminoma of the testis].
Ogawa O; Hashimoto K; Taniguchi T; Nakagawa T; Kusaka H; Takahashi R; Matsumoto S; Imai T
Hinyokika Kiyo; 1987 Dec; 33(12):2134-40. PubMed ID: 2452560
[TBL] [Abstract][Full Text] [Related]
33. [Endocrinology and fertility in stage I testicular tumor].
Joos H; Chandra I; Frick J
Helv Chir Acta; 1993 Dec; 60(3):367-70. PubMed ID: 7509783
[TBL] [Abstract][Full Text] [Related]
34. [Two cases of giant testicular tumor with widespread extension to the spermatic cord: usefulness of upfront chemotherapy].
Kin T; Kitsukawa S; Shishido T; Maeda Y; Izutani T; Yonese J; Fukui I
Hinyokika Kiyo; 1999 Mar; 45(3):191-4. PubMed ID: 10331173
[TBL] [Abstract][Full Text] [Related]
35. [Biological markers and germinal tumors of the testis. Value and limitations of the assay of chorionic gonadotrophin hormone and alpha-fetoprotein].
Bassoulet J; Pabot du Chatelard P; Ricordel I; Auberget JL; Guillemot MC; Merrer J; Timbal Y
J Urol (Paris); 1988; 94(8):393-6. PubMed ID: 2467947
[TBL] [Abstract][Full Text] [Related]
36. Detection of germ-cell tumor cells in the peripheral blood by nested reverse transcription-polymerase chain reaction for alpha-fetoprotein-messenger RNA and beta human chorionic gonadotropin-messenger RNA.
Hautkappe AL; Lu M; Mueller H; Bex A; Harstrick A; Roggendorf M; Ruebben H
Cancer Res; 2000 Jun; 60(12):3170-4. PubMed ID: 10866307
[TBL] [Abstract][Full Text] [Related]
37. [Retroperitoneal seminoma without testicular lesion. A case report and review of the literature].
Vermeulen C; Bouallouche A; Guillevin L; Sarfati E; Fitoussi C; Tricoire J
Sem Hop; 1984 Jan; 60(1):12-5. PubMed ID: 6198726
[TBL] [Abstract][Full Text] [Related]
38. Recurrence pattern and proposed surveillance protocol following post-chemotherapy retroperitoneal lymph node dissection.
Spiess PE; Brown GA; Liu P; Tu SM; Tannir NM; Evans JG; Kamat AM; Kassouf W; Pisters LL
J Urol; 2007 Jan; 177(1):131-8. PubMed ID: 17162023
[TBL] [Abstract][Full Text] [Related]
39. Spermatic blood beta HCG levels in testicular tumors and in varicocele.
Fiet J; Jardin A; Gourmel B; Villette JM; Guechot J; Gueux B
Prog Clin Biol Res; 1985; 203():117-20. PubMed ID: 2421324
[No Abstract] [Full Text] [Related]
40. Seminoma testis with elevated serum beta-HCG--a category of germ-cell cancer between seminoma and nonseminoma.
Dieckmann KP; Düe W; Bauer HW
Int Urol Nephrol; 1989; 21(2):175-84. PubMed ID: 2473044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
